...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Novel pH-sensitive non-ionic surfactant vesicles: Comparison between Tween 21 and Tween 20
【24h】

Novel pH-sensitive non-ionic surfactant vesicles: Comparison between Tween 21 and Tween 20

机译:新型pH敏感的非离子表面活性剂囊泡:吐温21和吐温20

获取原文
获取原文并翻译 | 示例
           

摘要

Drug delivery systems using vesicular carriers such as liposomes or niosomes, have distinct advantages over conventional dosage forms because the vesicles can act as drug containing reservoirs and the modification of the vesicular compositions or surface properties can adjust the drug release rate and/or the affinity for the target site. In recent years, niosomes have been the object of growing scientific attention as an alternative potential drug delivery system to conventional liposomes. The aim of present work was firstly to determine the critical micelle concentration (CMC) and then to analyze the capability of polysorbate 21 (Tween 21) to form niosomal formulations. Non-ionic surfactant vesicles were prepared using Tween 21 and cholesterol (CHOL) at equimolar ratio (15. mM:15. mM) by employing the " film" technique. Cholesterol was used to complete the hydrophobic moiety of single alkyl chain non-ionic surfactant for vesicle formation. Dynamic light scattering was used to determine the size, zeta (ζ)-potential, polydispersity index and colloidal stability of the niosomal formulation. The vesicles were also characterized for their microviscosity and pH-sensitivity using fluorescent probes. The present work led to a simple, but positive result in pharmaceutical technology area. In particular, we have shown that the Tween 21:CHOL vesicles (i) are a homogenous and monodisperse vesicular population; (ii) are characterized by dimension compatible with the transport of drugs across biological barriers especially those whose diameter is about 100nm; (iii) shows a good stability at least 90 days at 4°C and (iv) are pH-sensitive systems. In conclusion, this niosomal formulation could be used as pH-sensitive nanodevices for delivery of drugs to pathological tissues, which exhibit an acidic environment as compared to normal tissues.
机译:药物递送系统,诸如脂质体或NioSomes的囊状载体,与常规剂型具有不同的优点,因为囊泡可以用作含药物的储存器,并且囊状组合物或表面性质的改性可以调节药物释放速率和/或亲和力目标网站。近年来,定期组织是作为常规脂质体的替代潜在药物递送系统越来越大的对象。目前工作的目的首先是确定临界胶束浓度(CMC),然后分析聚山梨醇酯21(吐温21)以形成梭菌制剂的能力。通过采用“薄膜”技术,使用等摩尔比(15.mm:15μm),使用吐温21和胆固醇(Chol)制备非离子表面活性剂囊泡。胆固醇用于完成单烷基链非离子表面活性剂的疏水部分,用于囊泡形成。动态光散射用于确定憩室制剂的尺寸,Zeta(ζ) - 平稳,多分散性指数和胶体稳定性。囊泡的特征还表征了使用荧光探针的微伸张和pH敏感性。本工作导致了制药技术领域的简单但积极的结果。特别是,我们已经表明,Tween 21:Chol囊泡(I)是均匀的和单分散的囊状群; (ii)以与生物屏障的药物运输相容的维度,尤其是直径约为100nm的尺寸; (iii)显示在4℃和(iv)的良好稳定性至少90天,(IV)是pH敏感系统。总之,该定期组合制剂可以用作pH敏感的纳米纳米纳米纳米纳米型以将药物输送到病理组织,与正常组织相比表现出酸性环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号